Ana Migone
Family Medicine · Carbondale, ILNPI 1790753341
Payments from drug & device makers
Across 166 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$577
- AbbVie$575
- Astellas Pharma US Inc$439
- Pfizer$183
- GSK$160
- Dexcom, Inc.$157
- plus $898 from 23 others
What the payments were for
- Food & beverage$2,53685%
- Education$45315%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $577 |
| AbbVie(2 entities) | 37 | $575 |
| Astellas Pharma US Inc | 5 | $439 |
| Pfizer | 14 | $183 |
| GSK | 11 | $160 |
| Dexcom, Inc. | 9 | $157 |
| AstraZeneca | 10 | $145 |
| Amgen | 8 | $117 |
| Novartis | 6 | $108 |
| Lilly USA, LLC | 6 | $96 |
| Aimmune Therapeutics, Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Acadia Pharmaceuticals Inc | 2 | $35 |
| Sunovion Pharmaceuticals Inc. | 2 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| Boston Scientific | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 2 | $23 |
| Merck | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Mylan Specialty L.p. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| GE HealthCare | 1 | $16 |
| Bayer | 1 | $14 |
| Exact Sciences | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| UCB, Inc. | 1 | $12 |
How this compares
$2,989 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 155 | $194,249 |
| EliquisApixaban | 125 | $130,417 |
| RybelsusSemaglutide | 47 | $96,195 |
| TradjentaLinagliptin | 77 | $64,782 |
| OzempicSemaglutide | 39 | $64,667 |
| JanuviaSitagliptin Phosphate | 44 | $58,769 |
| TrulicityDulaglutide | 35 | $54,352 |
| FarxigaDapagliflozin Propanediol | 41 | $47,501 |
| ZenpepLipase/Protease/Amylase | 23 | $47,243 |
| LinzessLinaclotide | 29 | $35,820 |
| XareltoRivaroxaban | 42 | $35,242 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $29,597 |
| Repatha SureclickEvolocumab | 23 | $23,725 |
| DapagliflozinDapagliflozin Propanediol | 17 | $17,788 |
| VraylarCariprazine Hcl | 12 | $17,249 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $13 | $259,031232 claims |
| Novo NordiskRybelsus, Ozempic | $577 | $160,86286 claims |
| PfizerEliquis, Abrysvo | $183 | $135,904143 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $145 | $61,76562 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Shingrix | $160 | $58,77187 claims |
| MerckJanuvia | $21 | $58,76944 claims |
| Lilly USA, LLCTrulicity | $96 | $54,35235 claims |
| AbbVieLinzess, Vraylar | $575 | $53,06941 claims |
| Aimmune Therapeutics, Inc.Zenpep | $57 | $47,24323 claims |
| Johnson & JohnsonXarelto | $17 | $35,24242 claims |
| Astellas Pharma US IncMyrbetriq | $439 | $13,33711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Carbondale
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.